Year-over-year earnings per share growth for the last twelve months: Biomerica, Inc. (BMRA)

Outsourcing of production and IT solutions accelerates the issuance of reports, which supports the quarterly EPS growth rate; meanwhile, -46694.30 serves as the current level of this metric for Biomerica, Inc. (BMRA). Management remains concentrated in the hands of the founders with basic reporting transparency. Currently, Biomerica, Inc. (BMRA) is eschewing mergers in favor of organic growth and targeted partnerships with pharmacies to implement diagnostic systems.
Analytical breakdowns for Biomerica, Inc.

This indicator measures the percentage change in earnings per share between reporting periods, allowing conservative investors to filter out market noise and determine the fundamental value of the business. An analysis of quarterly EPS variation demonstrates how effectively the production and IT infrastructure outsourcing strategy of Biomerica, Inc. (BMRA) translates into real growth in shareholder equity, confirming the long-term sustainability of the operating model.